Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
3.830
-0.540 (-12.36%)
At close: Apr 1, 2025, 4:00 PM
4.087
+0.257 (6.70%)
After-hours: Apr 1, 2025, 4:11 PM EDT

Adverum Biotechnologies Market Cap

Adverum Biotechnologies has a market cap or net worth of $79.67 million as of April 1, 2025. Its market cap has decreased by -54.42% in one year.

Market Cap
79.67M
Enterprise Value
10.93M
1-Year Change
-54.42%
Ranking
Category
Stock Price
$3.83

Market Cap Chart

Since July 31, 2014, Adverum Biotechnologies's market cap has decreased from $581.50M to $79.67M, a decrease of -86.30%. That is a compound annual growth rate of -16.99%.

History

DateMarket Cap% Change
Mar 31, 202590.90M-6.39%
Dec 31, 202497.10M27.60%
Dec 29, 202376.10M31.66%
Dec 30, 202257.80M-66.53%
Dec 31, 2021172.70M-83.66%
Dec 31, 20201.06B42.01%
Dec 31, 2019744.10M275.81%
Dec 31, 2018198.00M25.63%
Dec 29, 2017157.60M30.25%
Dec 30, 2016121.00M-50.65%
Dec 31, 2015245.20M-79.79%
Dec 31, 20141.21B108.67%
View and export this data all the way back to 2014. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 738.61B
UnitedHealth Group 472.03B
Johnson & Johnson 394.52B
AbbVie 363.15B
Novo Nordisk 305.46B
AstraZeneca 229.16B
Abbott Laboratories 226.88B
Merck & Co. 225.40B
Market Cap Rankings